Treos Bio Overview

  • Founded
  • 2017
Founded
  • Status
  • Private
  • Employees
  • 20
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $14M
Latest Deal Amount
  • Investors
  • 6

Treos Bio General Information

Description

Developer of precision off-the-shelf and personalized peptide cancer immunotherapies designed to address an individual patient's clinical responses to cancer immunotherapies. The company uses computational data science and proprietary biomarkers to develop a unique ability to match the antigens expressed by a specific cancer to the individual patient's target recognition mechanism, enabling cancer patients to treat cancer through vaccines and diagnostic tests.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Outcome Management (Healthcare)
Biotechnology
Primary Office
  • The Harley Building
  • 79 New Cavendish Street
  • London W1W 6XB
  • England, United Kingdom
+44 020 0000 0000

Treos Bio Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Treos Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 31-Mar-2021 $14M 000.00 0000 Completed Clinical Trials - Phase 2
2. Early Stage VC (Series A) 30-Sep-2019 000.00 000.00 Completed Clinical Trials - Phase 1
1. Early Stage VC 13-Feb-2017 $8M $8M Completed Pre-Clinical Trials
To view Treos Bio’s complete valuation and funding history, request access »

Treos Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of precision off-the-shelf and personalized peptide cancer immunotherapies designed to address an individual p
Drug Discovery
London, United Kingdom
20 As of 2021
000.00
000 0000-00-00
0000000000 0 000.00

00000000

trud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in
0000 000000000
Rockville, MD
0 As of 0000
000.00
0000000000 0 000.00

000000 0

labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris ni
0000 000000000
Burlingame, CA
00 As of 0000
00000
000000 - 000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Treos Bio Competitors (32)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CytImmune Sciences Venture Capital-Backed Rockville, MD 0 000.00 0000000000 0 000.00
000000 00000000000 Formerly VC-backed Burlingame, CA 00 00000 000000 - 000 00000
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
00000000 Private Equity-Backed Holliston, MA 00 000.00 000000000 - 000.00
00000000 000000 00 Venture Capital-Backed Louisville, KY 000.00 0000000000 0 000.00
You’re viewing 5 of 32 competitors. Get the full list »

Treos Bio Executive Team (8)

Name Title Board Seat Contact Info
Christopher Gallen MD Chief Executive Officer & Chairman
Gabor Illés Chief Financial Officer & Board Member
John Hautman JD Chief Legal Officer
Enikő Tőke Ph.D Chief Scientific Officer & Board Member
Hagop Youssoufian MD Chair of Medical Strategy
You’re viewing 5 of 8 executive team members. Get the full list »

Treos Bio Board Members (8)

Name Representing Role Since
Christopher Gallen MD Treos Bio Chief Executive Officer & Chairman 000 0000
Daniel Hallgarten BXR Group Board Member 000 0000
Enikő Tőke Ph.D Treos Bio Chief Scientific Officer & Board Member 000 0000
Gabor Illés Treos Bio Chief Financial Officer & Board Member 000 0000
Isabel Fox Outsized Ventures Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Treos Bio Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Treos Bio Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Future Fund Government 000 0000 000000 0
Outsized Ventures Venture Capital Minority 000 0000 000000 0
Conor Fund Seed Capital Venture Capital Minority 000 0000 000000 0
SPRIM Ventures Corporate Venture Capital Minority 000 0000 000000 0
The Hopkins Capital Group PE/Buyout Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »